Project/Area Number |
22590669
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
General internal medicine (including Psychosomatic medicine)
|
Research Institution | Kanazawa Medical University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
SAIKI Ikuo 富山大学, 和漢医薬学総合研究所, 教授 (80133776)
TAKANO Fumihide 日本薬科大学, 薬学部, 准教授 (20236251)
MAKINO Toshikaki 名古屋市立大学, 大学院・薬学研究科, 准教授 (80326561)
|
Co-Investigator(Renkei-kenkyūsha) |
ISHIGAKI Yasuhito 金沢医科大学, 総合医学研究所, 准教授 (20232275)
SHIMASAKI Takeo 金沢医科大学, 総合医学研究所, 講師 (50377420)
|
Project Period (FY) |
2010 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2012: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2011: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2010: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Keywords | 大腸癌 / オキサリプラチン / 末梢神経障害 / 人参養栄湯 / 漢方 / 人参栄養湯 / 癌 / 内科 / 臨床 / 抗がん剤 |
Research Abstract |
In a pilot clinical trial, ninjinyoeito (NYT) was administered to 22 patients with advanced or recurrent colorectal cancer from the beginning of FOLFOX or XELOX, which contained oxaliplatin (L-OHP). Maximal peripheral neuropathy was grade2 in all patients during the observation period. In a mouse model, L-OHP (i.p.)induced cold hypersensitivity and mechanical allodynia, but NYT significantly attenuated these findings. In PC12 cells, L-OHP shortened nerve growth factor-induced neurite outgrowth, which NYT (300 μg/ml) recovered.
|